Mai Almohanna
- Co-authors
- Ayodele AlaiyaAbdelilah AboussekhraStig LinderHuda H. Al‐KhalafAli S. AlzahraniEbtesam QasemFahad Al‐KhodairyHindi Al‐Hindi
- Topics
- Cancer-related Molecular Pathways (5 papers)Nanoparticle-Based Drug Delivery (3 papers)Cancer Research and Treatments (3 papers)
- Partner nations
- Saudi ArabiaEgyptUnited States
In The Last Decade
Mai Almohanna
14 papers receiving 418 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 245
- Endocrinology, Diabetes and Metabolism 127
- Oncology 122
- Genetics 65
- Cancer Research 39
Countries citing papers authored by Mai Almohanna
This map shows the geographic impact of Mai Almohanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai Almohanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai Almohanna more than expected).
Fields of papers citing papers by Mai Almohanna
This network shows the impact of papers produced by Mai Almohanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai Almohanna. The network helps show where Mai Almohanna may publish in the future.
Co-authorship network of co-authors of Mai Almohanna
This figure shows the co-authorship network connecting the top 25 collaborators of Mai Almohanna. A scholar is included among the top collaborators of Mai Almohanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai Almohanna. Mai Almohanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 44 | |
| 4 | Enhanced Ehrlich tumor inhibition using DOX-NP and gold nanoparticles loaded liposomes. | 3 |
| 5 | 14 | |
| 6 | 31 | |
| 7 | 15 | |
| 8 | 13 | |
| 9 | 63 | |
| 10 | 17 | |
| 11 | 67 | |
| 12 | 68 | |
| 13 | 56 | |
| 14 | 29 |
About Mai Almohanna
Mai Almohanna is a scholar working on Biotechnology, Endocrinology, Diabetes and Metabolism and Biomaterials, having authored 14 papers that have together received 426 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (127 citations), Oncology (122 citations) and Molecular Biology (245 citations). Mai Almohanna has collaborated with scholars based in Saudi Arabia, Egypt and United States. Frequent co-authors include Ayodele Alaiya, Abdelilah Aboussekhra, Stig Linder, Huda H. Al‐Khalaf, Ali S. Alzahrani, Ebtesam Qasem, Fahad Al‐Khodairy, Hindi Al‐Hindi, Avaniyapuram Kannan Murugan and Pulicat Manogaran. Their work appears in journals such as Nucleic Acids Research, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.